NIH-funded research Career grant

Investigating how FGF21 affects metabolic syndrome after undernutrition refeeding

Official title: FGF21 protects from progressive metabolic syndrome after undernutrition refeeding

Funded at University of Texas Med Br Galveston · NIH-10786998 · Data updated 2026-11-12

This study is looking at how not getting enough nutrition as a child can lead to weight and health problems later in life, especially after eating normally again, and it’s using mice to see how a missing protein affects their eating habits and metabolism.

More Metabolic Syndrome research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Med Br Galveston
NIH-funded
Lab location1 site (Galveston, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2028
Funding year2024
Award (this year)$132,116
NIH project number1K01HL171461-01
Project IDNIH-10786998 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals over 21 years old who have a history of undernutrition or related metabolic issues.

Less likely to help

Patients who have not experienced undernutrition or do not have metabolic syndrome may not benefit from this research.

What this research studies

This research explores the impact of undernutrition during childhood on the development of metabolic syndrome (MetS) later in life, particularly after refeeding. It aims to understand how the loss of a protein called FGF21 may contribute to obesity, insulin resistance, and other metabolic issues. By using mouse models, the study will compare the effects of refeeding on normal mice and those lacking FGF21, focusing on behaviors like food preference and overeating. The findings could provide insights into the biological mechanisms behind MetS and potential interventions.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating metabolic syndrome in individuals who have experienced undernutrition.

How similar studies have gone: Previous research has indicated that understanding the role of proteins like FGF21 in metabolic processes can lead to significant advancements in treating metabolic disorders.

Where this research is happening

  • University of Texas Med Br Galveston
    Galveston, United States
    Active

Researchers

  • Principal investigator: Osorio, Elvia Janeth — University of Texas Med Br Galveston
  • Study coordinator: Osorio, Elvia Janeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.